April 9, 2025

Unlocking the Power of C1q in Autoimmune Disease and Therapeutic Innovation

In recent years, research on the complement system has achieved significant breakthroughs, particularly concerning the central protein C1q. 

Recognized as a vital initiator of the classical complement pathway, C1q also plays diverse roles in autoimmunity, inflammation, the progression of infectious diseases, and the development of therapeutic antibodies.

“C1q is more than just a complement protein—it’s a gatekeeper of immune tolerance.”— Dr. Leendert Trouw

 

April 9, 2025

Unlocking the Power of C1q in Autoimmune Disease and Therapeutic Innovation

In recent years, research on the complement system has achieved significant breakthroughs, particularly concerning the central protein C1q. 

Recognized as a vital initiator of the classical complement pathway, C1q also plays diverse roles in autoimmunity, inflammation, the progression of infectious diseases, and the development of therapeutic antibodies.

“C1q is more than just a complement protein—it’s a gatekeeper of immune tolerance.”— Dr. Leendert Trouw

 

Unlocking the Power of C1q in Autoimmune Disease and Therapeutic Innovation

C1q, a key component of the complement system, is gaining attention for its pivotal role in immune regulation and its emerging potential as a therapeutic target in autoimmune diseases. At Svar Life Science, we’re exploring how this molecule could reshape the future of diagnostics and drug development.

Expert Insights from Leading Researchers

In an exclusive interview, Dr. Leendert Trouw and Dr. Douwe Dijkstra—renowned experts in immunology—share their perspectives on:

  • The biological functions of C1q and its role in maintaining immune balance
  • How C1q dysregulation contributes to autoimmune conditions like lupus and rheumatoid arthritis
  • The latest research into C1q-targeted therapies and diagnostic tools

Why C1q Matters

Understanding C1q opens new doors in:

  • Early detection of autoimmune disorders
  • Personalized treatment strategies
  • Biomarker development for clinical trials

📥 Download the Full Interview

Get exclusive access to the full conversation with Dr. Trouw and Dr. Dijkstra. Learn how C1q is shaping the future of immunology and therapeutic innovation.


Please complete the form to get the full interview